Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 328

1.

Small molecule CXCR4 antagonists block the HIV-1 Nef/CXCR4 axis and selectively initiate the apoptotic program in breast cancer cells.

Huang MB, Giesler KE, Katzman BM, Prosser AR, Truax V, Liotta DC, Wilson LJ, Bond VC.

Oncotarget. 2018 Feb 26;9(24):16996-17013. doi: 10.18632/oncotarget.24580. eCollection 2018 Mar 30.

2.

A mouse model for evaluation of efficacy and concomitant toxicity of anti-human CXCR4 therapeutics.

Costa MJ, Kudaravalli J, Liu WH, Stock J, Kong S, Liu SH.

PLoS One. 2018 Mar 19;13(3):e0194688. doi: 10.1371/journal.pone.0194688. eCollection 2018.

3.

Expression of CXC-motif-chemokine 12 and the receptor C-X-C receptor 4 in glioma and theeffect on peritumoral brain edema.

Tang W, Chen Y, Wang X, Chen Y, Zhang J, Lin Z.

Oncol Lett. 2018 Feb;15(2):2501-2507. doi: 10.3892/ol.2017.7547. Epub 2017 Dec 8.

4.

Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3.

Murphy PM, Heusinkveld L.

Cytokine. 2018 Sep;109:2-10. doi: 10.1016/j.cyto.2017.12.022. Epub 2018 Feb 15. Review.

PMID:
29398278
5.

miRNA-23a/CXCR4 regulates neuropathic pain via directly targeting TXNIP/NLRP3 inflammasome axis.

Pan Z, Shan Q, Gu P, Wang XM, Tai LW, Sun M, Luo X, Sun L, Cheung CW.

J Neuroinflammation. 2018 Jan 31;15(1):29. doi: 10.1186/s12974-018-1073-0.

6.

The chemokines CXCL12 and CXCL14 differentially regulate connective tissue markers during limb development.

Nassari S, Blavet C, Bonnin MA, Stricker S, Duprez D, Fournier-Thibault C.

Sci Rep. 2017 Dec 8;7(1):17279. doi: 10.1038/s41598-017-17490-z.

7.

In the ovine pituitary, CXCR4 is localized in gonadotropes and somatotropes and increases with elevated serum progesterone.

Sanchez NS, Quinn KE, Ashley AK, Ashley RL.

Domest Anim Endocrinol. 2018 Jan;62:88-97. doi: 10.1016/j.domaniend.2017.10.003. Epub 2017 Oct 28.

PMID:
29157995
8.

The CXCL12/CXCR7 signaling axis, isoforms, circadian rhythms, and tumor cellular composition dictate gradients in tissue.

Spinosa PC, Luker KE, Luker GD, Linderman JJ.

PLoS One. 2017 Nov 8;12(11):e0187357. doi: 10.1371/journal.pone.0187357. eCollection 2017.

9.

CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma.

Werner TA, Forster CM, Dizdar L, Verde PE, Raba K, Schott M, Knoefel WT, Krieg A.

Br J Cancer. 2017 Dec 5;117(12):1837-1845. doi: 10.1038/bjc.2017.364. Epub 2017 Nov 7.

PMID:
29112684
10.

Cardioprotective Effect of the SDF-1α/CXCR4 Axis in Ischemic Postconditioning in Isolated Rat Hearts.

Kim JS, Jang Y, Kim JH, Park YH, Hwang SA, Kim J, Lee SR, Xu Z, Ban C, Ahn K, Chun KJ.

Korean Circ J. 2017 Nov;47(6):949-959. doi: 10.4070/kcj.2016.0353. Epub 2017 Sep 18.

11.

The effect of anagliptin on intimal hyperplasia of rat carotid artery after balloon injury.

Li Q, Wu X, Liu Y, Zhang M, Bai X, Chen C.

Mol Med Rep. 2017 Dec;16(6):8003-8010. doi: 10.3892/mmr.2017.7667. Epub 2017 Sep 29.

12.

Directional migration of mesenchymal stem cells under an SDF-1α gradient on a microfluidic device.

Park S, Jang H, Kim BS, Hwang C, Jeong GS, Park Y.

PLoS One. 2017 Sep 8;12(9):e0184595. doi: 10.1371/journal.pone.0184595. eCollection 2017.

13.

Chemokines as a Conductor of Bone Marrow Microenvironment in Chronic Myeloid Leukemia.

Mukaida N, Tanabe Y, Baba T.

Int J Mol Sci. 2017 Aug 22;18(8). pii: E1824. doi: 10.3390/ijms18081824. Review.

14.

Pharmacological modulation of C-X-C motif chemokine receptor 4 influences development of acute respiratory distress syndrome after lung ischaemia-reperfusion injury.

Nassoiy SP, Babu FS, LaPorte HM, Majetschak M.

Clin Exp Pharmacol Physiol. 2018 Jan;45(1):16-26. doi: 10.1111/1440-1681.12845. Epub 2017 Sep 20.

PMID:
28815665
15.

CXCL12 enhances angiogenesis through CXCR7 activation in human umbilical vein endothelial cells.

Zhang M, Qiu L, Zhang Y, Xu D, Zheng JC, Jiang L.

Sci Rep. 2017 Aug 15;7(1):8289. doi: 10.1038/s41598-017-08840-y.

16.

DACH1 stimulates shear stress-guided endothelial cell migration and coronary artery growth through the CXCL12-CXCR4 signaling axis.

Chang AH, Raftrey BC, D'Amato G, Surya VN, Poduri A, Chen HI, Goldstone AB, Woo J, Fuller GG, Dunn AR, Red-Horse K.

Genes Dev. 2017 Jul 1;31(13):1308-1324. doi: 10.1101/gad.301549.117. Epub 2017 Aug 4.

17.

Endothelial Notch signalling limits angiogenesis via control of artery formation.

Hasan SS, Tsaryk R, Lange M, Wisniewski L, Moore JC, Lawson ND, Wojciechowska K, Schnittler H, Siekmann AF.

Nat Cell Biol. 2017 Aug;19(8):928-940. doi: 10.1038/ncb3574. Epub 2017 Jul 17.

18.

Progressive Changes in CXCR4 Expression That Define Thymocyte Positive Selection Are Dispensable For Both Innate and Conventional αβT-cell Development.

Lucas B, White AJ, Parnell SM, Henley PM, Jenkinson WE, Anderson G.

Sci Rep. 2017 Jul 11;7(1):5068. doi: 10.1038/s41598-017-05182-7.

19.

Vascular CXCR4 Limits Atherosclerosis by Maintaining Arterial Integrity: Evidence From Mouse and Human Studies.

Döring Y, Noels H, van der Vorst EPC, Neideck C, Egea V, Drechsler M, Mandl M, Pawig L, Jansen Y, Schröder K, Bidzhekov K, Megens RTA, Theelen W, Klinkhammer BM, Boor P, Schurgers L, van Gorp R, Ries C, Kusters PJH, van der Wal A, Hackeng TM, Gäbel G, Brandes RP, Soehnlein O, Lutgens E, Vestweber D, Teupser D, Holdt LM, Rader DJ, Saleheen D, Weber C.

Circulation. 2017 Jul 25;136(4):388-403. doi: 10.1161/CIRCULATIONAHA.117.027646. Epub 2017 Apr 27.

PMID:
28450349
20.

Histone hypoacetylation contributes to CXCL12 downregulation in colon cancer: impact on tumor growth and cell migration.

Romain B, Benbrika-Nehmar R, Marisa L, Legrain M, Lobstein V, Oravecz A, Poidevin L, Bour C, Freund JN, Duluc I, Guenot D, Pencreach E.

Oncotarget. 2017 Jun 13;8(24):38351-38366. doi: 10.18632/oncotarget.16323.

Supplemental Content

Support Center